Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xyrem and Zolpidem in Obstructive Sleep Apnea
NCT00086281Phase 4Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Nov 2003
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of sodium oxybate in obstructive sleep apnea syndrome (OSAS), sponsored by Jazz Pharmaceuticals plc. Started Nov 2003; status: completed.
02
Drugs
sodium oxybate
03
Conditions
obstructive sleep apnea syndrome (OSAS)
Beyond the preview
Go deeper on NCT00086281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086281.